Genting Berhad
SEC CIK 1788489 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CELU | Celularity Inc | 10% | 6.34M | $5.35M | — | 2 | 2024-01-12 | 2025-01-24 |
Most active insiders at CELU, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LeVien Vincent | Dir | — | — |
| 2 | Brigido Stephen | Pres, Functional Regeneration | — | — |
| 3 | Haines John R | Senior Exec VP | — | — |
| 4 | Ling Geoffrey M.D. | Dir | — | — |
| 5 | Parks Diane L. | Dir | — | — |
| 6 | Diamandis Peter | Dir | — | — |
| 7 | Hariri Robert J | CEO, Dir | — | — |
Genting Berhad made no open-market trades at CELU in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-01-28 | 2025-01-24 | CELU | Celularity Inc | Genting Berhad | 10% | X - OptEx | $2.07 | +1.19M | 6.34M | +23% | +$2.46M |
| DI | 2024-01-17 | 2024-01-12 | CELU | Celularity Inc | Genting Berhad | 10% | P - Purchase | $0.25 | +21.41M | 51.47M | +71% | +$5.35M |
Purchase Sale Sale after option exercise All abbreviations